Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
Results from a phase 2 trial of lixisenatide have been published Date 4 April 2024 Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
New research study shows impact of delirium for people with Parkinson’s in hospital Date 21 March 2024 New research study shows impact of delirium for people with Parkinson’s in hospital
Skin biopsy as a potential method towards a test for Parkinson’s Date 21 March 2024 The simple skin test was able to detect a troublesome protein associated with Parkinson's and other similar conditions.
Parkinson’s UK funds nearly £450,000 for research exploring new ways to manage Parkinson’s symptoms Date 19 March 2024 Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson’s, without the need for extra medications.
How UK government plans to monitor bank accounts of benefit claimants will affect people with Parkinson’s Date 18 March 2024 In a move designed to combat welfare benefit fraud and error, the UK government wants the power to instruct banks to provide details of their customer's accounts, even where there is no suspicion of fraud.
Caption Emergency summit on time critical medication Emergency summit on time critical medication Date 15 March 2024 Patient groups, healthcare professionals and NHS England came together to take action to ensure people in hospital get their medication on time, every time.
Parkinson's UK teams up with Walking Football Scotland Date 12 March 2024 We’re teaming up with Walking Football Scotland to give people with Parkinson's more opportunities to play the game.
Caption Representatives from Bechet's UK, Crohn's and Colitis UK, the Cystic Fibrosis Trust, Parkinson's UK, the Pharmacists' Defence Association, the Royal College of GPs and the Royal Pharmaceutical Society outside the Department of Health and Social Care Campaigners call for the prescription charge to be frozen for the next 2 years in England Date 12 March 2024 The Prescription Charges Coalition have handed in a letter signed by over 600 people to freeze the charge at a time when costs are going up.
New treatment for Parkinson’s approved by NICE (The National Institute for Health and Care Excellence) Date 12 March 2024 Foslevodopa-foscarbidopa (also called Produodopa) has been approved by NICE in England, Northern Ireland and Wales and the Scottish Medicines Consortium for people with Parkinson’s who experience movement related symptoms.
New treatment for Parkinson’s made available on the NHS in England Date 12 March 2024 Foslevodopa-foscarbidopa (also called Produodopa) can be offered in England from 27 February for people with Parkinson’s who experience movement related symptoms.
